Share
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development (in English)
Potts, Steven J. ; Eberhard, David A. ; Wharton Jr, Keith A. (Author)
·
Humana
· Paperback
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development (in English) - Potts, Steven J. ; Eberhard, David A. ; Wharton Jr, Keith A.
$ 186.05
$ 310.08
You save: $ 124.03
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: United Kingdom
(Import costs included in the price)
It will be shipped from our warehouse between
Monday, June 10 and
Thursday, June 20.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development (in English)"
Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development gathers diverse experts to present state of the art guidance and application of histopathology in drug development settings ranging from discovery research to human clinical trials. While many current applications of quantitative histology and molecular pathology in the biopharmaceutical industry are focused on oncology, this volume in addition explores non-oncologic disease areas including nonalcoholic steatohepatitis, arthritis, celiac disease, myeloproliferative disorders, neurology, and wound healing. The authors write from years of experience in diagnostic practice and pharmaceutical drug development, aiming to educate pharmaceutical and academic scientists how to best use tissue to diagnose disease and improve the process of drug development. As part of the Methods in Pharmacology and Toxicology series, this volume is designed to provide wisdom and examples that others can follow and apply as part of drug development.Comprehensive and practical, Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development will inform and enlighten both tissue-focused and non-tissue-focused drug development professionals about better use and interpretation of the multidimensional data contained in a tissue biopsy.
